Numerof & Associates January 24, 2025
The challenges in bringing new products to market successfully have never been greater. In the past product approval meant demonstrating safety and efficacy to regulatory bodies in discrete countries—with a placebo comparator. Patients included in randomized clinical trials were subjected to inclusion and exclusion criteria based on disease parameters—not diversity in age, race, gender or other factors.
While...